A multistate platform model for time‐to‐event endpoints in oncology clinical trials
Abstract A multistate platform model was developed to describe time‐to‐event (TTE) endpoints in an oncology trial through the following states: initial, tumor response (TR), progressive disease (PD), overall survival (OS) event (death), censor to the last evaluable tumor assessment (progression‐free...
Saved in:
Main Authors: | Chih‐Wei Lin (Author), Mario Nagase (Author), Sameer Doshi (Author), Sandeep Dutta (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
by: Michael S. Yule, et al.
Published: (2024) -
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
by: Marianne J. Hjermstad, et al.
Published: (2024) -
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
by: James McDonald, et al.
Published: (2023) -
Evaluation of the True Endpoint of Clinical Trials for Cancer Cachexia
by: Tateaki Naito
Published: (2019) -
Patients' preferences for selection of endpoints in cardiovascular clinical trials
by: Robert D. Chow, et al.
Published: (2014)